CAMBRIDGE, Mass. — Neuroelectrics, a neuroscience devices designer, manufacturer and provider based in Spain, announced today the opening of its first U.S. office, located in the Cambridge Innovation Center (CIC) in Cambridge, Mass. Neuroelectrics expects to have three employees in Cambridge by the end of 2014.
“Thanks to our growth strategy of investing in education, innovation and infrastructure, Massachusetts continues to lead the world in life sciences,” said Governor Deval Patrick. “We welcome Neuroelectrics to Massachusetts and look forward to their contributions to our thriving life sciences community.”
Neuroelectrics aims to become the trusted leader in Brain Health by providing measurement tools and making neuromodulation affordable and available for every patient in need. “We believe that our technologies will open a new wide window for the observation of the human brain and enable effective, innovative treatments for many pathologies,” said Neuroelectrics CEO, Ana Maiques.
The company currently offers two devices: StarStim, a neuro-stimulator using the transcranial Current Stimulation (tCS) technique that is currently being used for research purposes in pathologies such as pain, depression, and post-stroke rehabilitation; and Enobio, a wireless electroencephalography (EEG) brain monitoring device aimed at neurofeedback research, Brain Computer Interfaces (BCI) and basic neuroscience research.
“Massachusetts was the right choice for our first international branch,” said Maiques. “We already have a number of strong clients and partners in the area such as Beth Israel Deaconess Medical Center, MIT, Boston University, Boston Children Hospital, Spaulding Rehabilitation Center, Brown University, UMass Lowell and VA Boston, among others. Our presence in the area will allow us to provide a better service. Second, Prof. Alvaro Pascual-Leone, the Director of the Berenson-Allen Center for Non-invasive Brain Stimulation at the Beth Israel Deaconess Medical Center and an Associate Dean for Clinical and Translational Research at Harvard Medical School is a Scientific Advisor of the company and we have a very strong collaboration, so it is fantastic to be able to follow up the work they are doing more closely. Third and most important, we consider Boston a unique ecosystem in which talent, business and investment are present and that would allow us to boost our company growth in the perfect environment.”
“On behalf of the Center, I would like to extend our warmest congratulations to the team at Neuroelectrics as they open their first U.S. office here in Massachusetts,” said Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center, the agency charged with implementing Governor Patrick’s 10-year, $1 billion Life Sciences Initiative. “The Commonwealth of Massachusetts has one of the strongest concentrations of neuroscience talent in the world, and Neuroelectrics is a welcome addition to our neuroscience community. We are thrilled that the Neuroelectrics team has chosen Massachusetts and look forward to partnering with them as they grow their business in Massachusetts.”
“I am very happy that Neuroelectrics chose Cambridge as the location for its first international branch,” said Senator Sal DiDomenico. “I am certain they will be a great addition to the thriving life sciences community here in Massachusetts.”
Neuroelectrics worked closely with the Massachusetts Life Sciences Center as they developed their plans for their first U.S. office.
Neuroelectrics’ new U.S. office is based at:
Neuroelectrics
Cambridge Innovation Center
1 Broadway, 14th floor
Cambridge, MA 02142
USA
About Neuroelectrics
Neuroelectrics is a Starlab spin-off. We aim to become the trusted leader in Brain Health by providing measurement tools and making neuromodulation affordable and available for every patient in need. We believe that our new technologies will open a new wide window for the observation of the human brain and enable effective, innovative treatments for many pathologies.
About the Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a 10-year, $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences. For more information, visit www.masslifesciences.com.
MLSC Disclaimer: This announcement is not intended to be a commercial endorsement of any products or services provided or developed by the entities referenced in this release.
Help employers find you! Check out all the jobs and post your resume.
